This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Management of prostatic carcinoma

Authoring team

Patients considering a PSA test should be informed that at present:

  • early detection and treatment of prostate cancer may be beneficial
  • identifying men at greatest risk of prostate cancer or identifying which patients will benefit from further investigations and treatment is indecisive
  • no strong evidence to indicate which treatment option is most suitable for which man;
  • active treatments have significant side-effects, although improvements to treatment regimes and their side-effects are being made (1)

The management of prostatic carcinoma depends on the disease stage:

  • organ-confined
  • locally advanced
  • advanced, metastatic

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.